Biblio
Found 3 results
Filters: Author is Laul, E. [Clear All Filters]
.
2025. Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven Inflammation. Journal of the American Chemical Society Au. 5:2491-2499.
.
2024. Structure-based design of CBP/EP300 degraders: when cooperativity overcomes affinity. Journal of the American Chemical Society Au. 4(9):3466-3474.
.
2020. Hitting a moving target: simulation and crystallography study of ATAD2 bromodomain blockers. ACS Medicinal Chemistry Letters. 11(8):1573-1580.